Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Vladimir, Feygelman"'
Autor:
J. M. Bryant, Ruben J. Cruz-Chamorro, Alberic Gan, Casey Liveringhouse, Joseph Weygand, Ann Nguyen, Emily Keit, Maria L. Sandoval, Austin J. Sim, Bradford A. Perez, Thomas J. Dilling, Gage Redler, Jacqueline Andreozzi, Louis Nardella, Arash O. Naghavi, Vladimir Feygelman, Kujtim Latifi, Stephen A. Rosenberg
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-10 (2024)
Abstract Background Definitive local therapy with stereotactic ablative radiation therapy (SABR) for ultracentral lung lesions is associated with a high risk of toxicity, including treatment related death. Stereotactic MR-guided adaptive radiation th
Externí odkaz:
https://doaj.org/article/89ae1961f1fb40c7bc42f9f286e60874
Autor:
Arash O. Naghavi, J. M. Bryant, Youngchul Kim, Joseph Weygand, Gage Redler, Austin J. Sim, Justin Miller, Kaitlyn Coucoules, Lauren Taylor Michael, Warren E. Gloria, George Yang, Stephen A. Rosenberg, Kamran Ahmed, Marilyn M. Bui, Evita B. Henderson-Jackson, Andrew Lee, Caitlin D. Lee, Ricardo J. Gonzalez, Vladimir Feygelman, Steven A. Eschrich, Jacob G. Scott, Javier Torres-Roca, Kujtim Latifi, Nainesh Parikh, James Costello
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Soft tissue sarcomas (STS), have significant inter- and intra-tumoral heterogeneity, with poor response to standard neoadjuvant radiotherapy (RT). Achieving a favorable pathologic response (FPR ≥ 95%) from RT is associated with
Externí odkaz:
https://doaj.org/article/760ccdc9553b448b8e8ca970aa410459
Autor:
John Michael Bryant, MD, Matthew N. Mills, MD, George Q. Yang, MD, Casey Liveringhouse, MD, Russell Palm, MD, Peter A. Johnstone, MD, Justin T. Miller, BS, Kujtim Latifi, PhD, Vladimir Feygelman, PhD, Arash O. Naghavi, MD, MS
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 4, Pp 101447- (2024)
Purpose: Soft tissue sarcomas (STS) are historically radioresistant, with surgery being an integral component of their treatment. With their low α/β, STS may be more responsive to hypofractionated radiation therapy (RT), which is often limited by l
Externí odkaz:
https://doaj.org/article/637bfcb0aace44cd932063f72a8ecb29
Autor:
Matthew Mills, MD, Justin Miller, CMD, Casey Liveringhouse, MD, John M. Bryant, MD, Yuki Kawahara, MD, Vladimir Feygelman, PhD, Kujtim Latifi, PhD, George Yang, MD, Peter A. Johnstone, MD, Arash O. Naghavi, MD, MS
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 3, Pp 101391- (2024)
Purpose: Hypofractionated radiation therapy (RT) offers benefits in the treatment of soft tissue sarcomas (STS), including exploitation of the lower α/β, patient convenience, and cost. This study evaluates the acute toxicity of a hypofractionated a
Externí odkaz:
https://doaj.org/article/04da270f99d2452cab1019f5b58abdad
Autor:
Maria L. Sandoval, MD, MS, Austin J. Sim, MD, JD, John M. Bryant, MD, Menal Bhandari, MD, Evan J. Wuthrick, MD, Bradford A. Perez, MD, Thomas J. Dilling, MD, MS, Gage Redler, PhD, Jacqueline Andreozzi, PhD, Louis Nardella, PhD, Vladimir Feygelman, PhD, Kujtim Latifi, PhD, Stephen A. Rosenberg, MD, MS
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 5, Pp 100488- (2023)
Introduction: The recent results from the Nordic-HILUS study indicate stereotactic body radiation therapy (SBRT) is associated with high-grade toxicity for ultracentral (UC) tumors. We hypothesized that magnetic resonance-guided SBRT (MRgSBRT) or hyp
Externí odkaz:
https://doaj.org/article/430160b637cf4ceabce524d50df38ab8
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The treatment of central and ultracentral lung tumors with radiotherapy remains an ongoing clinical challenge. The risk of Grade 5 toxicity with ablative radiotherapy doses to these high-risk regions is significant as shown in recent prospective stud
Externí odkaz:
https://doaj.org/article/b0f1e01bb93949d58bacb63e9c6b55a1
Autor:
Rebecka Ericsson-Szecsenyi MSc, Geoffrey Zhang PhD, Gage Redler PhD, Vladimir Feygelman PhD, Stephen Rosenberg MD, Kujtim Latifi PhD, Crister Ceberg PhD, Eduardo G. Moros PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Purpose: Radiomics entails the extraction of quantitative imaging biomarkers (or radiomics features) hypothesized to provide additional pathophysiological and/or clinical information compared to qualitative visual observation and interpretation. This
Externí odkaz:
https://doaj.org/article/3b60da7dc30d449796011a4f3aedef26
Autor:
Austin J. Sim, Russell F. Palm, Kirby B. DeLozier, Vladimir Feygelman, Kujtim Latifi, Gage Redler, Iman R. Washington, Evan J. Wuthrick, Stephen A. Rosenberg
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 25, Iss , Pp 102-106 (2020)
Aims: To assess the safety and efficacy of MR-guided stereotactic body radiation therapy (MRgSBRT) for cardiac metastases. Materials/methods: This single institution retrospective analysis evaluated our experience with MRgSBRT for cardiac metastases.
Externí odkaz:
https://doaj.org/article/302db9ecad0b4c8097eb27de69eaf378
Autor:
Jihye Koo, Louis Nardella, Michael Degnan, Jacqueline Andreozzi, Hsiang-hsuan M. Yu, Jose Penagaricano, Peter A. S. Johnstone, Daniel Oliver, Kamran Ahmed, Stephen A. Rosenberg, Evan Wuthrick, Roberto Diaz, Vladimir Feygelman, Kujtim Latifi, Eduardo G. Moros, Gage Redler
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Purpose: To monitor intrafraction motion during spine stereotactic body radiotherapy(SBRT) treatment delivery with readily available technology, we implemented triggered kV imaging using the on-board imager(OBI) of a modern medical linear accelerator
Externí odkaz:
https://doaj.org/article/b67572372270419fab00b788561d35ad
Autor:
Evangelia Katsoulakis, Randi Kudner, Christina Chapman, John Park, Lindsay Puckett, Abhi Solanki, Rishabh Kapoor, Michael Hagan, Maria Kelly, Jatinder Palta, Roy Tishler, Ying Hitchcock, Bhisham Chera, Vladimir Feygelman, Gary Walker, David Sher, Ksenija Kujundzic, Emily Wilson, Samantha Dawes, Sue S. Yom, Louis Harrison
Publikováno v:
Practical Radiation Oncology. 12:409-423
Safeguarding high-quality care using evidence-based radiation therapy for patients with head and neck cancer is crucial to improving oncologic outcomes, including survival and quality of life.The Veterans Administration (VA) National Radiation Oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f85580794a84d7d3c98d1749d8ec32
https://doi.org/10.1016/j.prro.2022.05.009
https://doi.org/10.1016/j.prro.2022.05.009